Capasso, Anna
 Distribuzione geografica
Continente #
EU - Europa 308
NA - Nord America 188
AS - Asia 120
AF - Africa 3
Totale 619
Nazione #
US - Stati Uniti d'America 180
IT - Italia 135
SG - Singapore 69
IE - Irlanda 66
ID - Indonesia 21
SE - Svezia 21
CN - Cina 14
CZ - Repubblica Ceca 14
FR - Francia 14
DE - Germania 13
FI - Finlandia 13
RU - Federazione Russa 10
CA - Canada 7
GB - Regno Unito 6
IN - India 4
KR - Corea 4
NL - Olanda 4
BE - Belgio 3
LT - Lituania 3
BT - Bhutan 2
CH - Svizzera 2
CI - Costa d'Avorio 2
PK - Pakistan 2
PL - Polonia 2
TR - Turchia 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
IL - Israele 1
PA - Panama 1
RS - Serbia 1
ZA - Sudafrica 1
Totale 619
Città #
Dublin 62
Rome 54
Singapore 54
Ashburn 35
Chandler 26
New York 26
Jakarta 21
Milan 17
Brno 12
Helsinki 9
Boardman 7
Palermo 6
Toronto 6
London 5
Marseille 5
Moscow 5
Munich 4
Paris 4
Seoul 4
Amsterdam 3
Boston 3
Bremen 3
Caorle 3
Grottaferrata 3
Houston 3
Lappeenranta 3
Princeton 3
Ronciglione 3
Seattle 3
Trieste 3
Abidjan 2
Beijing 2
Bengaluru 2
Busto Arsizio 2
Cagliari 2
Cattolica 2
Ciserano 2
Frankfurt am Main 2
Kazan' 2
Liège 2
Los Angeles 2
Padova 2
Perugia 2
Priolo Gargallo 2
Pune 2
Reggio Emilia 2
Ronchis 2
Salò 2
San Mateo 2
Sandston 2
Shanghai 2
Thimphu 2
Washington 2
Andover 1
Aversa 1
Brdo 1
Brussels 1
Capoterra 1
Civitavecchia 1
Dubai 1
Durban 1
Genoa 1
Harbin 1
Jarrow 1
Kragujevac 1
Krakow 1
Leawood 1
Lugano 1
Mantova 1
Naaldwijk 1
Naples 1
Ottawa 1
Pasadena 1
Piscataway 1
Prague 1
Ranica 1
Sant'Agostino 1
Springfield 1
Teramo 1
Vienna 1
Warsaw 1
Zurich 1
Totale 470
Nome #
Prevalence of Spinal Muscular Atrophy in the Era of Disease-Modifying Therapies: An Italian Nationwide Survey 88
Neurological assessment of newborns with spinal muscular atrophy identified through neonatal screening 78
Assessing floppy infants: a new module 63
Nusinersen efficacy data for 24-month in type 2 and 3 spinal muscular atrophy 60
Onasemnogene abeparvovec in spinal muscular atrophy: predictors of efficacy and safety in naïve patients with spinal muscular atrophy and following switch from other therapies 59
A Longitudinal Follow-Up Study of Intellectual Function in Duchenne Muscular Dystrophy over Age: Is It Really Stable? 39
A Longitudinal Follow-Up Study of Intellectual Function in Duchenne Muscular Dystrophy over Age: Is It Really Stable? 28
Early neurological signs in infants identified through neonatal screening for SMA: do they predict outcome? 26
Longitudinal Analysis of PUL 2.0 Domains in Ambulant and Non-Ambulant Duchenne Muscular Dystrophy Patients: How do they Change in Relation to Functional Ability? 26
Long term follow-up of scoliosis progression in type II SMA patients 22
Prevalence of Spinal Muscular Atrophy in the Era of Disease-Modifying Therapies: An Italian Nationwide Survey 22
Gain and loss of upper limb abilities in Duchenne muscular dystrophy patients: A 24-month study 20
Can the CHOP-INTEND be used as An Outcome Measure in the First Months of Age? Implications for Clinical Trials and Real World Data 18
Patient reported outcome measure for upper limb in Duchenne muscular dystrophy: correlation with PUL2.0 15
Clinical Phenotype of Pediatric and Adult Patients With Spinal Muscular Atrophy With Four SMN2 Copies: Are They Really All Stable? 14
Early treatment of type II SMA slows rate of progression of scoliosis 13
Longitudinal Analysis of PUL 2.0 Domains in Ambulant and Non-Ambulant Duchenne Muscular Dystrophy Patients: How do they Change in Relation to Functional Ability? 13
Communicative development inventory in type 1 and presymptomatic infants with spinal muscular atrophy: a cohort study 12
Prevalence of Spinal Muscular Atrophy in the Era of Disease-Modifying Therapies: An Italian Nationwide Survey 11
Profile of cognitive abilities in spinal muscular atrophy type II and III: what is the role of motor impairment? 10
A Longitudinal Follow-Up Study of Intellectual Function in Duchenne Muscular Dystrophy over Age: Is It Really Stable? 10
Totale 647
Categoria #
all - tutte 4.930
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.930


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202229 0 0 0 0 0 0 0 0 1 3 3 22
2022/2023153 14 16 4 11 5 7 20 16 14 5 15 26
2023/2024321 9 39 14 17 11 45 54 10 7 20 57 38
2024/2025144 11 8 44 37 44 0 0 0 0 0 0 0
Totale 647